Friday, December 14, 2007

PEG Interferon: Post grant opposition

Roche was amongst the first recepients of product patents in the pharma space. It received product patent [IN198952] in India in 2006 for its product - Pegasys [pegylated interferon alpha 2a].

While the Pegasys product patent is under post grant opposition by Wockhardt; an NGO Sankalp too filed a post grant opposition in May 2007 against this product.
Copy of Sankalp's Opposition.

No comments: